1,980
Views
0
CrossRef citations to date
0
Altmetric
Research article

Role of platelet count in a murine stasis model of deep vein thrombosis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2290916 | Received 08 Aug 2023, Accepted 29 Nov 2023, Published online: 15 Dec 2023

References

  • Waheed SM, Kudaravalli P, Hotwagner DT. Deep vein thrombosis. Treasure Island (FL): StatPearls; 2021.
  • Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711–9. doi:10.1001/archinte.163.14.1711.
  • Parker K, Thachil J. The use of direct oral anticoagulants in chronic kidney disease. Br J Haematol. 2018;183(2):170–84. doi:10.1111/bjh.15564.
  • Naringrekar H, Sun J, Ko C, Rodgers SK. It’s not all deep vein thrombosis: sonography of the painful lower extremity with multimodality correlation. J Ultrasound Med. 2019;38(4):1075–89. doi:10.1002/jum.14776.
  • Seifi A, Dengler B, Martinez P, Godoy DA. Pulmonary embolism in severe traumatic brain injury. J Clin Neurosci. 2018;57:46–50. doi:10.1016/j.jocn.2018.08.042.
  • Deatrick KB, Elfline M, Baker N, Luke CE, Blackburn S, Stabler C, Wakefield TW, Henke PK. Postthrombotic vein wall remodeling: preliminary observations. J Vasc Surg. 2011;53(1):139–46. doi:10.1016/j.jvs.2010.07.043.
  • Rabinovich A, Cohen JM, Cushman M, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Lazo‐Langner A, Solymoss S, et al. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. J Thromb Haemost. 2015;13(3):398–408. doi:10.1111/jth.12814.
  • Kim YA, Yang SS, Yun WS. Does catheter-directed thrombolysis prevent postthrombotic syndrome? Vasc Specialist Int. 2018;34(2):26–30. doi:10.5758/vsi.2018.34.2.26.
  • Yoo T, Aggarwal R, Wang TF, Satiani B, Haurani MJ. Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis. Vasc Surg Venous Lymphat Disord. 2018;6(5):575–583 e1. doi:10.1016/j.jvsv.2017.12.059.
  • Ho KM, Yip CB, Duff O. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost. 2012;10(9):1768–74. doi:10.1111/j.1538-7836.2012.04846.x.
  • Diaz JA, Saha P, Cooley B, Palmer OR, Grover SP, Mackman N, Wakefield TW, Henke PK, Smith A, Lal BK, et al. Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application. J Thromb Haemost. 2019;17(4):699–707. doi:10.1111/jth.14413.
  • Mwiza JMN, Lee RH, Paul DS, Holle LA, Cooley BC, Nieswandt B, Schug WJ, Kawano T, Mackman N, Wolberg AS, et al. Both G protein–coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice. Blood. 2022;139(21):3194–3203. doi:10.1182/blood.2022015787.
  • von Bruhl ML, Stark K, Steinhart A, von Brühl M-L, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–35. doi:10.1084/jem.20112322.
  • DeRoo E, Martinod K, Cherpokova D, Fuchs T, Cifuni S, Chu L, Staudinger C., Wagner DD. The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis. J Thromb Haemost. 2021;19(2):387–399. doi:10.1111/jth.15134.
  • Shirai T, Revenko AS, Tibbitts J, Ngo ATP, Mitrugno A, Healy LD, Johnson J, Tucker EI, Hinds MT, Coussens LM, et al. Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice. Blood Adv. 2019;3(20):3080–3091. doi:10.1182/bloodadvances.2019000250.
  • Crooke ST, Baker BF, Xia S, Yu RZ, Viney NJ, Wang Y, Tsimikas S, Geary RS. Integrated assessment of the clinical performance of GalNAc 3 -conjugated 2′- O -methoxyethyl chimeric antisense oligonucleotides: I. Human volunteer experience. Nucleic Acid Ther. 2019;29(1):16–32. doi:10.1089/nat.2018.0753.
  • Prakash TP, Graham MJ, Yu J, Carty R, Low A, Chappell A, Schmidt K, Zhao C, Aghajan M, Murray HF, et al. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res. 2014;42(13):8796–807. doi:10.1093/nar/gku531.
  • Nguyen KP, McGilvray KC, Puttlitz CM, Mukhopadhyay S, Chabasse C, Sarkar R, Sen U. Matrix metalloproteinase 9 (MMP-9) regulates vein wall biomechanics in murine thrombus resolution. PLoS One. 2015;10(9):e0139145. doi:10.1371/journal.pone.0139145.
  • Frey MK, Alias S, Winter MP, Redwan B, Stübiger G, Panzenboeck A, Alimohammadi A, Bonderman D, Jakowitsch J, Bergmeister H, et al. Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc. 2014;3(1):e000772. doi:10.1161/JAHA.113.000772.
  • Nosaka M, Ishida Y, Kuninaka Y, Ishigami A, Taruya A, Shimada E, Hashizume Y, Yamamoto H, Kimura A, Furukawa F, et al. Intrathrombotic appearances of AQP-1 and AQP-3 in relation to thrombus age in murine deep vein thrombosis model. Int J Legal Med. 2021;135(2):547–53. doi:10.1007/s00414-020-02482-y.
  • Nosaka M, Ishida Y, Kimura A, Kuninaka Y, Taruya A, Ozaki M, Tanaka A, Mukaida N, Kondo T. Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes. Front Immunol. 2019;10:3150. doi:10.3389/fimmu.2019.03150.
  • Nosaka M, Ishida Y, Kimura A, Kuninaka Y, Taruya A, Furuta M, Mukaida N, Kondo T. Contribution of the TNF-α (Tumor Necrosis Factor-α)–TNF-Rp55 (Tumor Necrosis Factor Receptor p55) axis in the resolution of venous thrombus. Arterioscler Thromb Vasc Biol. 2018;38(11):2638–2650. doi:10.1161/ATVBAHA.118.311194.
  • Jordan KR, Wyatt CR, Fallon ME, Woltjer R, Neuwelt EA, Cheng Q, Gailani D, Lorentz C, Tucker EI, McCarty OJT, et al. Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis. J Thromb Haemost. 2022;20(9):2035–45. doi:10.1111/jth.15777.
  • Hisada Y, Garratt KB, Maqsood A, Grover SP, Kawano T, Cooley BC, Erlich J, Moik F, Flick MJ, Pabinger I, et al. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. Blood Adv. 2021;5(2):487–495. doi:10.1182/bloodadvances.2020003149.
  • Hisada Y, Ay C, Auriemma AC, Cooley BC, Mackman N. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size. J Thromb Haemost. 2017;15(11):2208–17. doi:10.1111/jth.13809.
  • Nicklas JM, Gordon AE, Henke PK. Resolution of deep venous thrombosis: proposed immune paradigms. Int J Mol Sci. 2020;21(6). doi:10.3390/ijms21062080.
  • Qian S, Fu F, Li W, Chen Q, de Sauvage FJ. Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood. 1998;92(6):2189–91. doi:10.1182/blood.V92.6.2189.
  • Bhat FA, Advani J, Khan AA, Mohan S, Pal A, Gowda H, Chakrabarti P, Keshava Prasad TS, Chatterjee A. A network map of thrombopoietin signaling. J Cell Commun Signal. 2018;12(4):737–743. doi:10.1007/s12079-018-0480-4.
  • Barrett TJ, Wu BG, Revenko AS, MacLeod AR, Segal LN, Berger JS. Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets. J Thromb Haemost. 2020;18(7):1773–82. doi:10.1111/jth.14808.
  • Tucker EI, Marzec UM, Berny MA, Hurst S, Bunting S, McCarty OJT, Gruber A, Hanson SR. Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates. Sci Transl Med. 2010;2(37):37ra45. doi:10.1126/scitranslmed.3000697.
  • Koupenova M, Kehrel BE, Corkrey HA, Freedman JE. Thrombosis and platelets: an update. Eur Heart J. 2017;38(11):785–791. doi:10.1093/eurheartj/ehw550.
  • Mackman N. New insights into the mechanisms of venous thrombosis. J Clin Invest. 2012;122(7):2331–6. doi:10.1172/JCI60229.
  • Torisu T, Torisu K, Lee IH, Liu J, Malide D, Combs CA, Wu XS, Rovira II, Fergusson MM, Weigert R, et al. Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat Med. 2013;19(10):1281–7. doi:10.1038/nm.3288.
  • Stark K, Philippi V, Stockhausen S, Busse J, Antonelli A, Miller M, Schubert I, Hoseinpour P, Chandraratne S, von Brühl M-L, et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood. 2016;128(20):2435–49. doi:10.1182/blood-2016-04-710632.
  • Diaz JA, Hawley AE, Alvarado CM, Berguer A, Baker N, Wrobleski S, Wakefield T, Lucchesi B, Myers D. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost. 2010;104(2):366–75. doi:10.1160/TH09-09-0672.
  • Baldwin JF, Sood V, Elfline MA, Luke CE, Dewyer NA, Diaz JA, Myers DD, Wakefield T, Henke PK. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J Vasc Surg. 2012;56(4):1089–97. doi:10.1016/j.jvs.2012.02.054.
  • Dewyer NA, Sood V, Lynch EM, Luke CE, Upchurch GR, Wakefield TW, Kunkel S, Henke PK. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res. 2007;142(2):357–63. doi:10.1016/j.jss.2007.03.064.
  • Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411–20. doi:10.1016/j.jacc.2017.09.024.
  • Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Luscher TF. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation. 1998;97(2):181–7. doi:10.1161/01.cir.97.2.181.
  • Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–4738. doi:10.1182/bloodadvances.2020001830.
  • Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64–77. doi:10.1016/S0140-6736(20)32658-1.
  • Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367(21):1979–87. doi:10.1056/NEJMoa1210384.
  • Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012;366(21):1959–67. doi:10.1056/NEJMoa1114238.